Abstract
Long term, low dose administration of adriamycin (ADR) to young growing rabbits resulted in significant alterations in bone structure and chemistry. Morphologic changes were most pronounced at epiphyseal and metaphyseal areas of long bones. Epiphyseal cartilage plates were thin and there was derangement of growth zones. Areas of primary and secondary spongiosa were deficient in trabeculae, osteoblasts and osteoclasts. Analysis of femora, humeri and lumbar vertebrae from ADR-treated rabbits revealed increased water and fat content and significant decreases in bone density compared to age-matched controls. Cortices of long bones were roentgenographically thin and contained large irregular spaces evident microscopically. Evaluation of bone ash from ADR treated rabbits revealed significant increases in the percentage of calcium and phosphorus, although Ca/P ratios were not different from controls. Results ofin vitro studies indicate that ADR binds readily to nondemineralized, but not demineralized, fresh cortical bone powder.
The findings of decreased bone density, histopathologic alterations, and a paucity of osteogenic cells in ADR treated rabbits are interpreted as retardation of bone maturation. It is suggested that ADR affects adversely both the organic and inorganic fractions of bone. Due to its unique characteristics of cytostatic action, binding to metal cations and orange-red fluorescence, ADR is a novel chemical agent that may be useful in experimental bone studies.
Similar content being viewed by others
References
Arcamone, F., Cassinelli, G., Franceschi, G., Penco, S., Pol, C., Redaelli, S., Selva, A.: Structure and physiochemical properties of adriamycin (doxorubicin). In: International symposium on adriamycin (S. K. Carter, A. DiMarco, M. Ghione, I. H. Krakoff, G. Mathe, eds.), p. 9–22, New York: Springer, Inc. 1972
Au, W. Y. W., Raisz, L. G.: Drugs toxic to bone Seminars in Drug Treatment2, 137–146 (1972)
Babson, A. L.: Phenolphthalein monophosphate, a new substrate for alkaline phosphatase. Clin. Chem. (Abstract)II, 789 (1965)
Barzel, U. S., Morecki, R., Spigland, I.: Endochondral (provisional) calcificationin vitro. Clin. Orthop.78, 191–194 (1971)
Birkenhager, J. C., Heul, R. O. van der, Smeenk, D., Sluys Veer, J., van der Seters, A. P. van: Bone changes associated with glucocorticoid excess. Proc. roy. Soc. Med.60, 28–30 (1967)
Blum, R. H., Carter, S. K.: Adriamycin-a new anticancer drug with significant clinical activity. Ann. intern. Med.80, 249–259 (1974)
Burnell, J. M., Teubner, E., Wergedal, J. E., Sherrard, D. J.: Bone crystal maturation in renal osteodystrophy in humans J. clin. Invest.53, 52–58 (1974)
Chapin, R. E., Smith, S. E.: The calcium tolerance of growing and reproducing rabbits. Cornell Vet.57, 480–491 (1967)
Chapin, R. E., Smith, S. E.: Calcium requirement of growing rabbits. J. anim. Sci.26, 67–71 (1967)
Cochran, M., Bulusu, L., Horsman, A., Stasiak, L., Nordin, B. E. C.: Hypocalcaemia and bone disease in renal failure. Nephron10, 113–140 (1973)
Cohlan, S. Q., Bevelander, G., Tiamsic, T.: Growth inhibition of prematures receiving tetracycline. Amer. J. Dis. Child105, 65–73 (1963)
Elias, E. G., Evans, J. T.: Mithramycin in the treatment of Paget’s disease of bone. J. Bone Jt Surg. A54, 1730–1736 (1972)
Fennelly, J. J., Groarke, J. F.: Effect of actinomycin D on Paget’s disease of bone. Brit. med. J.1971 I, 423–426
Freireich, E. J., Genhan, E. A., Rall, D. P., Schmidt, L. H., Skipper, H. E.: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep.50, 219–244 (1966)
Hawk, P. B., Oser, B. L., Summerson, W. H.: Practical physiological chemistry, 13th edition, p. 559–565. New York: The Blakiston, Co., Inc. 1954
Hulth, A., Lindberg, L.: Effect of actinomycin D on epiphyseal plate of mice. Acta path. microbiol. scand.73, 177–182 (1968)
Jaenke, R. S.: An anthracycline antibiotic-induced cardiomyopathy in rabbits. Lab. Invest.30, 292–304 (1974)
Kleeman, C. R., Better, O. S.: Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment. Kidney Intetnat4, 73–79 (1973)
Lefrak, E. A., Pitha, J., Rosenheim, S., Gottlieb, J. A.: A clincopathologic analysis of adriamycin cardiotoxicity. Cancer (Philad.)32, 302–314 (1973)
Mankin, H. J.: Rickets, osteomalacia and renal osteodystrophy. J. Bone Jt Surg. A56, Part I, 101–128; Part II, 352–386 (1974)
Marsh, W. H., Fingerhut, B., Kirsch, E.: Determination of urea nitrogen with the diacetyl method and an automatic dialyzing apparatus. Amer. J. clin. Path.28, 681–688 (1957)
Mattingly, D.: A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J. clin. Path.14, 374–379 (1962)
Minkin, C.: Inhibition of parathyroid hormone stimulated bone resorptionin vitro by the antibiotic mithramycin. Calcif. Tiss. Res.13, 249–257 (1973)
O’Bryan, R. M., Luce, J. K., Talley, R. W., Gottleib, J. A., Baker, L. H., Bonadonna, G.: Phase II evaluation of adriamycin in human neoplasia. Cancer (Philad.)32, 1–8 (1973)
Posner, A. S.: Bone mineral on the molecular level. Fed. Proc.32, 1933–1954 (1973)
Potts, J. T., Jr., Deftos, L. J.: Parathyroid hormone, thyrocalicitonin, vitamin D, bone and bone mineral metabolism. In: Duncan’s diseases of metabolism (P. K. Bondy, ed.), 6th ed., p. 904–1082. Philadelphia: W. B. Saunders Co. 1969
Rasmussen, H., Bordier, P.: The cellular basis of metabolic bone disease. New Engl. J. Med.289, 25–32 (1973)
Robinson, R. A., Elliott, S. R.: The water content of bone. J. Bone Jt Surg. A39, 167–188 (1957)
Russell, J. E., Termine, J. D., Avioli, L. V.: Abnormal bone mineral maturation in the chronic uremic state. J. clin. Invest.52, 2842–2852 (1973)
Schachter, D.: The fluorometric estimation of magnesium in serum and in urine. J. Lab. clin. Med.54, 763–768 (1959)
Skeggs, L. T.: An automatic method for colorimetric analysis. Amer. J. clin. Path.28, 311–321 (1957)
Stanbury, S. W.: Bone disease in uraemia. Amer. J. Med.44, 714–724 (1968)
Steel, R. G. D., Torrie, J. H.: Principles and procedures of statistics. New York: McGraw-Hill Book Co., Inc. 1960
Tan, C., Etcubanas, E., Wollner, N., Rosen, G., Gilladoga, A., Showel, J., Murphy, M. L., Krakoff, I. H. Adriamycin—an antitumor antibiotic in the treatment of neoplastic diseases Cancer (Philad.)32, 9–17 (1973)
Thompson, J. S., Urist, M. R.: Effects of cortisone on bone metabolism in intact and thyroidectomized rabbits. Calcif. Tiss. Res.13, 197–215 (1973)
Weinstein, L.: Antibioties; III. The tetracyclines. In: The pharmacological basis of therapeutics (L. S. Goodman, A. Gilman, eds.), 4th ed., p. 1253–1268. New York: The Macmillian Co. 1970
West, V. C., Storey, E.: Thein vitro effect of fluoride and tetracycline on phase transformation of a calcium phosphate. Calcif. Tiss. Res.9, 207–215 (1972)
Yesair, D. W., Bittman, L., Schwartzbach, E.: Pharmacodynamic significance of metal chelates of the anthracycline drugs (NSC-82151 and NSC-123127). Proc. Amer. Ass. Cancer Res. (Abstract)15, 72 (1974)
Young, D. M., Olson, H. M., Fioravanti, J. L., Prieur, D. J.: Adriamycin-induced bone lesions in rabbits. Fed. Proc. (Abstract)33, 608 (1974)
Young, D. M., Prieur, D. J., Fioravanti, J. L.: Clinicopathologic effects of long-term adriamycin administration to rabbits. Proc. Amer. Ass. Cancer Res. (Abstract)15, 103 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, D.M., Fioravanti, J.L., Olson, H.M. et al. Chemical and morphologic alterations of rabbit bone induced by adriamycin. Calc. Tis Res. 18, 47–63 (1975). https://doi.org/10.1007/BF02546226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02546226